triazoles has been researched along with Myocardial Infarction in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.45) | 18.7374 |
| 1990's | 5 (17.24) | 18.2507 |
| 2000's | 6 (20.69) | 29.6817 |
| 2010's | 17 (58.62) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Assmann, G; Brenner, C; Brunner, S; David, R; Franz, WM; Gross, L; Mueller-Hoecker, J; Nathan, P; Steinbeck, G; Theiss, HD; Vallaster, M; Vogeser, M | 1 |
| de Wijs-Meijler, D; Duncker, DJ; Jan Danser, AH; Jankowski, J; Jankowski, V; Lankhuizen, I; Merkus, D; Zhou, Z | 1 |
| Andersson, C; Mogensen, UM; Scheller, NM; Torp-Pedersen, C; Vaag, A | 1 |
| Begum, SS; Hausenloy, DJ; Mocanu, MM; Riksen, N; Theodorou, L; Whittington, HJ; Wynne, AM; Yellon, DM | 1 |
| Bethel, MA; Califf, RM; Green, JB; Holman, RR; Kaufman, KD; Paul, SK; Ring, A; Shapiro, DR | 1 |
| Birnbaum, Y; Kodakandla, M; Ling, S; Nanhwan, MK; Nylander, S; Ye, Y | 1 |
| Chang, NC; Chen, WT; Lee, TM; Lin, SZ; Yang, CC | 1 |
| Fukushima, A; Furihata, T; Harashima, S; Homma, T; Kadoguchi, T; Kinugawa, S; Masaki, Y; Matsumoto, J; Matsushima, S; Mizushima, W; Okita, K; Takada, S; Takahashi, M; Tanaka, S; Tsutsui, H; Yokota, T | 1 |
| Bian, X; Hong, L; Liu, Y; Sun, Y; Teng, T; Xu, J; Xu, Z | 1 |
| Brenner, C; Engelmann, MG; Franz, WM; Henschel, V; Huber, B; Mansmann, U; Reiser, M; Steinbeck, G; Theiss, HD; Wintersperger, B; Zaruba, MM | 1 |
| Ban, K; Drucker, DJ; Henkelman, RM; Husain, M; Momen, MA; Sauvé, M; Zhou, YQ | 1 |
| Birnbaum, Y; Keyes, KT; Lin, Y; Perez-Polo, JR; Ye, Y; Zhang, C | 1 |
| Aytemir, K; Canpolat, U; Kaya, EB; Oto, A; Sunman, H | 1 |
| Lochner, A; Moolman, JA; Salie, R | 1 |
| Bajaj, M; Birnbaum, Y; Castillo, AC; Ling, S; Perez-Polo, JR; Qian, J; Ye, H; Ye, Y | 1 |
| Advani, A; Advani, SL; Connelly, KA; Gilbert, RE; Thai, K; Yuen, DA; Zhang, Y | 1 |
| Huisamen, B | 1 |
| Andreadou, I; Iliodromitis, E; Kremastinos, DT; Papalois, A; Siatra, T; Tasouli, A; Tsantili-Kakoulidou, A | 1 |
| Ballard-Croft, C; Keith, BJ; Kristo, G; Lasley, RD; Mentzer, RM; Reid, EA; Yoshimura, Y | 1 |
| Amerson, BS; Guyton, RA; Halkos, ME; Headrick, JP; Kerendi, F; Kin, H; Lofye, MT; Vinten-Johansen, J; Zatta, AJ; Zhao, ZQ | 1 |
| Suggs, L; Wang, X; Wang, Z; Zhang, G; Zhang, J | 1 |
| Auchampach, JA; Ge, ZD; Gross, GJ; Jacobson, MA; Kreckler, LM; Peart, JN; Wan, TC | 1 |
| Alloatti, G; Cacace, G; Camussi, G; Comino, A; De Filippi, PG; Emanuelli, G; Mariano, F; Montrucchio, G; Polloni, R | 1 |
| Black, SC; Driscoll, EM; Lucchesi, BR | 1 |
| Chakrabarty, S; Flores, NA; Fluck, DS; Sheridan, DJ | 1 |
| Leong, LL; Stephens, CJ; Sturm, MJ; Taylor, RR | 1 |
| Hachisuka, M; Inoue, T; Inubushi, T; Kinoshita, M; Mitsunami, K; Okada, M | 1 |
| Henkel, C; Müller, JH; Weser, C | 1 |
2 trial(s) available for triazoles and Myocardial Infarction
| Article | Year |
|---|---|
Rationale, design, and organization of a randomized, controlled Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) in patients with type 2 diabetes and established cardiovascular disease.
Topics: Aged; Aged, 80 and over; Angina, Unstable; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Myocardial Infarction; Pioglitazone; Pyrazines; Research Design; Sitagliptin Phosphate; Stroke; Sulfonylurea Compounds; Thiazolidinediones; Treatment Outcome; Triazoles | 2013 |
Safety and efficacy of SITAgliptin plus GRanulocyte-colony-stimulating factor in patients suffering from Acute Myocardial Infarction (SITAGRAMI-Trial)--rationale, design and first interim analysis.
Topics: Adult; Aged; Aged, 80 and over; Drug Therapy, Combination; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Male; Middle Aged; Myocardial Infarction; Pyrazines; Sitagliptin Phosphate; Treatment Outcome; Triazoles | 2010 |
27 other study(ies) available for triazoles and Myocardial Infarction
| Article | Year |
|---|---|
Antidiabetic gliptins in combination with G-CSF enhances myocardial function and survival after acute myocardial infarction.
Topics: Adamantane; Animals; Cell Survival; Drug Therapy, Combination; Granulocyte Colony-Stimulating Factor; Heart; Hypoglycemic Agents; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; Nitriles; Pyrazines; Pyrrolidines; Sitagliptin Phosphate; Triazoles; Vildagliptin | 2013 |
Blunted coronary vasodilator response to uridine adenosine tetraphosphate in post-infarct remodeled myocardium is due to reduced P1 receptor activation.
Topics: Adenosine A2 Receptor Antagonists; Adenosine Diphosphate; Animals; Coronary Vessels; Dinucleoside Phosphates; Heart; Myocardial Infarction; Myocardium; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Purinergic P2Y Receptor Antagonists; Pyridoxal Phosphate; Pyrimidines; Receptors, Purinergic; Receptors, Purinergic P1; Theophylline; Triazoles; Vasodilator Agents; Ventricular Remodeling | 2013 |
All-cause mortality and cardiovascular effects associated with the DPP-IV inhibitor sitagliptin compared with metformin, a retrospective cohort study on the Danish population.
Topics: Denmark; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dipeptidyl-Peptidase IV Inhibitors; Female; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Pyrazines; Retrospective Studies; Sitagliptin Phosphate; Stroke; Treatment Outcome; Triazoles | 2014 |
Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner.
Topics: Adamantane; Animals; Cyclic AMP-Dependent Protein Kinases; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose; Heart; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nitriles; Pyrazines; Pyrrolidines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Glucagon; Severity of Illness Index; Signal Transduction; Sitagliptin Phosphate; Triazoles; Vildagliptin | 2013 |
Chronic treatment with ticagrelor limits myocardial infarct size: an adenosine and cyclooxygenase-2-dependent effect.
Topics: 6-Ketoprostaglandin F1 alpha; Adenosine; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Animals; Aspirin; Cardiotonic Agents; Clopidogrel; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Drug Evaluation, Preclinical; Enzyme Induction; Lipoxins; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Nitric Oxide Synthase Type III; Pyrazoles; Quinazolines; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Receptor, Adenosine A2A; Ticagrelor; Ticlopidine; Triazoles; Up-Regulation | 2014 |
Sitagliptin attenuates sympathetic innervation via modulating reactive oxygen species and interstitial adenosine in infarcted rat hearts.
Topics: Adenosine; Animals; Heart; Male; Myocardial Infarction; Pyrazines; Rats; Rats, Wistar; Reactive Oxygen Species; Sitagliptin Phosphate; Triazoles | 2015 |
Dipeptidyl peptidase-4 inhibitor improved exercise capacity and mitochondrial biogenesis in mice with heart failure via activation of glucagon-like peptide-1 receptor signalling.
Topics: Animals; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Exenatide; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Male; Mice, Inbred C57BL; Mitochondria; Muscle, Skeletal; Myocardial Infarction; Organelle Biogenesis; Peptides; Triazoles; Venoms | 2016 |
Adenosine A
Topics: Adenosine-5'-(N-ethylcarboxamide); Animals; Electron Transport Complex I; Humans; Membrane Potential, Mitochondrial; Mitochondria; Mutation; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; NADH Dehydrogenase; Oxidative Stress; Purines; Pyrimidines; Rats; Receptors, Adenosine A2; Triazoles | 2017 |
Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice.
Topics: Animals; Cardiovascular System; Coronary Vessels; Diabetes Mellitus, Experimental; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Gene Deletion; Heart; Hypoglycemic Agents; Male; Metformin; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; Myocardial Ischemia; Pyrazines; Reference Values; Reperfusion; Sitagliptin Phosphate; Survivors; Triazoles | 2010 |
The myocardial infarct size-limiting effect of sitagliptin is PKA-dependent, whereas the protective effect of pioglitazone is partially dependent on PKA.
Topics: Animals; Blood Glucose; Blotting, Western; Body Weight; Culture Media; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dipeptidyl-Peptidase IV Inhibitors; Eicosanoids; Glucagon-Like Peptide 1; Hypertrophy, Left Ventricular; Hypoglycemic Agents; In Vitro Techniques; Mice; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Organ Size; Phospholipases A2; Pioglitazone; Prostaglandin-Endoperoxide Synthases; Protective Agents; Pyrazines; Sitagliptin Phosphate; Thiazolidinediones; Triazoles | 2010 |
Myocardial infarction due to coronary thrombus formation in a postmenopausal woman with breast cancer after initiation of letrozol therapy.
Topics: Aromatase Inhibitors; Breast Neoplasms; Coronary Thrombosis; Electrocardiography; Female; Humans; Letrozole; Middle Aged; Myocardial Infarction; Nitriles; Postmenopause; Radiography; Triazoles | 2012 |
The mechanism of beta-adrenergic preconditioning: roles for adenosine and ROS during triggering and mediation.
Topics: Adenosine; Animals; Ethanolamines; Extracellular Signal-Regulated MAP Kinases; Formoterol Fumarate; Ischemic Preconditioning, Myocardial; Isoproterenol; Myocardial Infarction; Phosphatidylinositol 3-Kinases; Potassium Channels; Protein Kinase C; Proto-Oncogene Proteins c-akt; Rats; Reactive Oxygen Species; Receptors, Adrenergic, beta; Receptors, Purinergic P1; Triazines; Triazoles | 2012 |
Phosphodiesterase III inhibition increases cAMP levels and augments the infarct size limiting effect of a DPP-4 inhibitor in mice with type-2 diabetes mellitus.
Topics: Animals; Blood Glucose; Cilostazol; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Diabetes Mellitus, Type 2; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glucagon-Like Peptide 1; Glycated Hemoglobin; Immunoblotting; Lipids; Lipoxins; Male; Membrane Proteins; Mice; Myocardial Infarction; Myocardium; Phosphodiesterase 3 Inhibitors; PTEN Phosphohydrolase; Tetrazoles; Triazoles | 2012 |
DPP-4 inhibition attenuates cardiac dysfunction and adverse remodeling following myocardial infarction in rats with experimental diabetes.
Topics: Animals; Diabetes Mellitus, Experimental; Dipeptidyl-Peptidase IV Inhibitors; Heart; Myocardial Infarction; Pyrazines; Rats; Rats, Inbred F344; Sitagliptin Phosphate; Streptozocin; Triazoles; Ventricular Remodeling | 2013 |
Cyclic AMP and PKA: how can a lot of good come from the potentially bad? : editorial to: "phosphodiesterase III inhibition increases cAMP levels and augments the infarct size limiting effect of a DPP-4 inhibitor in mice with type-2 diabetes mellitus" by Y
Topics: Animals; Cilostazol; Cyclic AMP; Diabetes Mellitus, Type 2; Male; Myocardial Infarction; Phosphodiesterase 3 Inhibitors; Tetrazoles; Triazoles | 2012 |
Reduction of myocardial infarct size in rabbits by a novel indole derivative with antioxidant and free radical scavenging properties.
Topics: Animals; Antioxidants; Biphenyl Compounds; Chromatography, High Pressure Liquid; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Free Radical Scavengers; Free Radicals; Heart Injuries; Hydroxyl Radical; Indoles; Male; Malondialdehyde; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Picrates; Rabbits; Triazoles | 2002 |
Top 10 health stories of 2003.
Topics: Aging; Angioplasty, Balloon, Coronary; Antineoplastic Agents; Breast Neoplasms; Dietary Carbohydrates; Disease Outbreaks; Genome, Human; Guideline Adherence; Hormone Replacement Therapy; Humans; Hypertension; Letrozole; Myocardial Infarction; Nitriles; Obesity; Public Health; Severe Acute Respiratory Syndrome; Triazoles | 2003 |
In vivo adenosine receptor preconditioning reduces myocardial infarct size via subcellular ERK signaling.
Topics: Animals; Butadienes; Enzyme Inhibitors; Imidazoles; Ischemic Preconditioning, Myocardial; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocardial Infarction; Nitriles; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Reperfusion Injury; Subcellular Fractions; Triazines; Triazoles; Xanthines | 2005 |
Postconditioning reduces infarct size via adenosine receptor activation by endogenous adenosine.
Topics: Adenosine; Animals; Male; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Perfusion; Purinergic P1 Receptor Antagonists; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Theophylline; Triazines; Triazoles; Xanthines | 2005 |
A PEGylated fibrin patch for mesenchymal stem cell delivery.
Topics: Animals; Cell Differentiation; Cells, Cultured; Fibrin; Fibrinogen; Mesenchymal Stem Cells; Myocardial Infarction; Polyethylene Glycols; Stem Cell Transplantation; Swine; Time Factors; Triazoles | 2006 |
Cl-IB-MECA [2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide] reduces ischemia/reperfusion injury in mice by activating the A3 adenosine receptor.
Topics: Adenosine; Adenosine A3 Receptor Agonists; Animals; Blood Pressure; Cardiotonic Agents; Cell Degranulation; Cells, Cultured; Cyclic AMP; Dose-Response Relationship, Drug; Histamine; In Vitro Techniques; Male; Mice; Mice, Knockout; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; p-Methoxy-N-methylphenethylamine; Pyridines; Radioligand Assay; Receptor, Adenosine A3; Triazines; Triazoles | 2006 |
Role of platelet-activating factor in polymorphonuclear neutrophil recruitment in reperfused ischemic rabbit heart.
Topics: Animals; Azepines; Cell Movement; Female; Heart; Hemodynamics; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Neutrophils; Platelet Activating Factor; Quinolines; Rabbits; Risk Factors; Triazoles | 1993 |
Inhibition of platelet-activating factor fails to limit ischemia and reperfusion-induced myocardial damage.
Topics: Animals; Azepines; Blood Pressure; Coronary Circulation; Dogs; Heart Rate; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Platelet Activating Factor; Platelet Aggregation; Triazoles | 1992 |
Effects of the PAF antagonists BN50726 and BN50739 on arrhythmogenesis and extent of necrosis during myocardial ischaemia/reperfusion in rabbits.
Topics: Animals; Arrhythmias, Cardiac; Azepines; Blood Pressure; Electrocardiography; Heart Rate; Hemodynamics; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Necrosis; Platelet Activating Factor; Rabbits; Thienopyridines; Triazoles | 1992 |
Effect of WEB 2086 on myocardial infarct size and regional blood flow in the dog.
Topics: Animals; Azepines; Cardiac Output; Coronary Disease; Disease Models, Animal; Dogs; Myocardial Infarction; Myocardium; Platelet Activating Factor; Regional Blood Flow; Triazoles | 1992 |
In vivo 31P nuclear magnetic resonance spectroscopy in patients with old myocardial infarction.
Topics: Adenosine Triphosphate; Adult; Aged; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Myocardial Infarction; Phosphocreatine; Triazoles | 1992 |
[Use of rocornal in emergencies].
Topics: Angina Pectoris; Emergencies; Ethylamines; Humans; Myocardial Infarction; Pyrimidines; Triazoles; Vasodilator Agents | 1972 |